Print ISSN:-2394-2789
Online ISSN:-2394-2797
CODEN : IJPCN9
Review Article
Author Details :
Volume : 6, Issue : 1, Year : 2019
Article Page : 1-5
https://doi.org/10.18231/j.ijpca.2019.001
Abstract
Pirfenidone is a broad-spectrum antifibrotic medicine. In 2014, it was approved for the treatment of the idiopathic pulmonary fibrosis (IPF) by the U.S. Food and Drug Administration. Terizidone is WHO categorized group IV anti TB drug. It is an antibiotic effective against Mycobacterium tuberculosis and also M. avium for the treatment of tuberculosis, both pulmonary and extra pulmonary. The fundamental aim of this article to assemble all reported analytical methods for qualitative and quantitative analysis of Pirfenidone and Terizidone in pharmaceutical formulation as well as in biological fluids. It consist of Spectroscopy, high performance liquid chromatography, High performance thin layer chromatography.
Keywords: Pirfenidone, Terizidone, Antifibrotic, Idiopathic pulmonary fibrosis, Analytical method.
How to cite : Shirkhedkar A A, Khan M M G, Chaudhari P, Pawara P I, Analytical techniques for Pirfenidone and Terizidone: A review. Int J Pharm Chem Anal 2019;6(1):1-5
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.